

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.46417845 |
| 2 | nuclear pore complex assembly (GO:0051292) | 4.76343224 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.51180189 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.29106232 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.29106232 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20089871 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.15480130 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.15480130 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.15480130 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.15480130 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.15480130 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.15480130 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05153928 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.03698640 |
| 15 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.99601601 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 3.98550157 |
| 17 | histone H3-K36 demethylation (GO:0070544) | 3.87852125 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87358883 |
| 19 | response to interleukin-15 (GO:0070672) | 3.78542562 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78468140 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74770068 |
| 22 | regulation of histone H3-K27 methylation (GO:0061085) | 3.72441845 |
| 23 | nuclear pore organization (GO:0006999) | 3.69944895 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.66540860 |
| 25 | negative regulation of interleukin-1 production (GO:0032692) | 3.64528633 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.63274288 |
| 27 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.60360659 |
| 28 | pore complex assembly (GO:0046931) | 3.47560873 |
| 29 | germinal center formation (GO:0002467) | 3.43727982 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42628341 |
| 31 | positive regulation of growth hormone secretion (GO:0060124) | 3.38519960 |
| 32 | response to peptidoglycan (GO:0032494) | 3.20020400 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.19624210 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.14890028 |
| 35 | positive regulation of granulocyte differentiation (GO:0030854) | 3.13624586 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 3.11887397 |
| 37 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.11625024 |
| 38 | detection of other organism (GO:0098543) | 3.09482390 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.05308200 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 3.05084343 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05062390 |
| 42 | response to host immune response (GO:0052572) | 3.05062390 |
| 43 | negative T cell selection (GO:0043383) | 3.04429036 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.03059913 |
| 45 | cellular extravasation (GO:0045123) | 3.01572776 |
| 46 | response to host (GO:0075136) | 2.98605055 |
| 47 | response to host defenses (GO:0052200) | 2.98605055 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98605055 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.93652385 |
| 50 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91202143 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91202143 |
| 52 | T cell homeostasis (GO:0043029) | 2.89518436 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.88969047 |
| 54 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88322624 |
| 55 | regulation of RNA export from nucleus (GO:0046831) | 2.87189693 |
| 56 | regulation of B cell differentiation (GO:0045577) | 2.86895323 |
| 57 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86612640 |
| 58 | response to muramyl dipeptide (GO:0032495) | 2.86609769 |
| 59 | detection of bacterium (GO:0016045) | 2.83854813 |
| 60 | detection of external biotic stimulus (GO:0098581) | 2.81351514 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 2.79029230 |
| 62 | histone H3-K4 trimethylation (GO:0080182) | 2.77822071 |
| 63 | thymic T cell selection (GO:0045061) | 2.76831579 |
| 64 | leukocyte aggregation (GO:0070486) | 2.76654974 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.75524518 |
| 66 | embryonic process involved in female pregnancy (GO:0060136) | 2.74781028 |
| 67 | positive thymic T cell selection (GO:0045059) | 2.74582253 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.74539977 |
| 69 | interferon-gamma secretion (GO:0072643) | 2.73802947 |
| 70 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72541202 |
| 71 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.72516192 |
| 72 | T cell selection (GO:0045058) | 2.69714148 |
| 73 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.69590217 |
| 74 | positive regulation of interferon-alpha production (GO:0032727) | 2.69194341 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.68778727 |
| 76 | type I interferon signaling pathway (GO:0060337) | 2.68778727 |
| 77 | response to type I interferon (GO:0034340) | 2.68196053 |
| 78 | iron ion import (GO:0097286) | 2.65475356 |
| 79 | histone lysine demethylation (GO:0070076) | 2.60647192 |
| 80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.60484663 |
| 81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.60474720 |
| 82 | positive T cell selection (GO:0043368) | 2.59603407 |
| 83 | B cell homeostasis (GO:0001782) | 2.58819532 |
| 84 | lymphocyte homeostasis (GO:0002260) | 2.58686778 |
| 85 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.58050906 |
| 86 | neutrophil activation (GO:0042119) | 2.57182167 |
| 87 | hepatocyte apoptotic process (GO:0097284) | 2.55893342 |
| 88 | regulation of growth hormone secretion (GO:0060123) | 2.53396023 |
| 89 | Peyers patch development (GO:0048541) | 2.51972623 |
| 90 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.51972623 |
| 91 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51492128 |
| 92 | regulation of necroptotic process (GO:0060544) | 2.47799031 |
| 93 | negative regulation of interleukin-6 production (GO:0032715) | 2.46524507 |
| 94 | B cell proliferation (GO:0042100) | 2.46414355 |
| 95 | histone demethylation (GO:0016577) | 2.45972699 |
| 96 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.45759502 |
| 97 | definitive hemopoiesis (GO:0060216) | 2.45211867 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 2.43519910 |
| 99 | regulation of granulocyte differentiation (GO:0030852) | 2.40448115 |
| 100 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.39742214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.43834023 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.28365595 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.25382537 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.95719821 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.42627159 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.31141041 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26996427 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.03122098 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.03073628 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84311960 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64602880 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.53881518 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.53309522 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47633590 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40353259 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35898073 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.35108045 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32327759 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31265472 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.26797531 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.22615446 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19204948 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15822009 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.15141714 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15043622 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11951538 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96213090 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95782934 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93798244 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92358118 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91032911 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88847389 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87504282 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77978764 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76797967 |
| 36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.74637408 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.74297695 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.73614245 |
| 39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.71792040 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66434484 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66010891 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64843563 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.63307727 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60242896 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59768243 |
| 46 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.57726742 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54774137 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46927560 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.45574433 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45216107 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41665073 |
| 52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36941345 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35986060 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35690190 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35404857 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34144623 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31794644 |
| 58 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.31574960 |
| 59 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29119203 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28464642 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26919723 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26731722 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26010194 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21975165 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21322993 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19972358 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19044897 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17746404 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16624135 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16398586 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16281204 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15823958 |
| 73 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15397791 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11980306 |
| 75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10257406 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07927526 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07249875 |
| 78 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06355579 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05696919 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05370123 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04830100 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04401257 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.03817260 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03812715 |
| 85 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03450745 |
| 86 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03450745 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99884368 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96990037 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96920995 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95902928 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94889605 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94696219 |
| 93 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94133844 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93484587 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90743242 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89788352 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89055537 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88798374 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86789037 |
| 100 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86667192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.12411947 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.09076457 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.77488528 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.73132474 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.59525863 |
| 6 | MP0003724_increased_susceptibility_to | 2.56396337 |
| 7 | MP0004381_abnormal_hair_follicle | 2.53808583 |
| 8 | MP0003436_decreased_susceptibility_to | 2.48171670 |
| 9 | MP0001800_abnormal_humoral_immune | 2.36188863 |
| 10 | MP0003303_peritoneal_inflammation | 2.33388848 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.24252240 |
| 12 | MP0005451_abnormal_body_composition | 2.21143138 |
| 13 | MP0008057_abnormal_DNA_replication | 2.19904880 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.14498362 |
| 15 | MP0000685_abnormal_immune_system | 2.12235861 |
| 16 | MP0005387_immune_system_phenotype | 2.12088618 |
| 17 | MP0001790_abnormal_immune_system | 2.12088618 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.07627139 |
| 19 | MP0002398_abnormal_bone_marrow | 2.02043698 |
| 20 | MP0002419_abnormal_innate_immunity | 2.01548643 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.00324808 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.00001750 |
| 23 | MP0001819_abnormal_immune_cell | 1.97581604 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.94891660 |
| 25 | MP0002723_abnormal_immune_serum | 1.92921726 |
| 26 | MP0005025_abnormal_response_to | 1.83923182 |
| 27 | MP0000703_abnormal_thymus_morphology | 1.78475441 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.75818171 |
| 29 | MP0002006_tumorigenesis | 1.73009060 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.72999533 |
| 31 | MP0000716_abnormal_immune_system | 1.69543593 |
| 32 | MP0002722_abnormal_immune_system | 1.68990645 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.66853685 |
| 34 | MP0009785_altered_susceptibility_to | 1.63057378 |
| 35 | MP0002405_respiratory_system_inflammati | 1.61256921 |
| 36 | MP0004947_skin_inflammation | 1.61141387 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.60622587 |
| 38 | MP0002009_preneoplasia | 1.59449493 |
| 39 | MP0005671_abnormal_response_to | 1.58088588 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.55921742 |
| 41 | MP0009278_abnormal_bone_marrow | 1.50031153 |
| 42 | MP0002429_abnormal_blood_cell | 1.47494214 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.46530022 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46022790 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.39368741 |
| 46 | MP0009697_abnormal_copulation | 1.38603097 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.38382709 |
| 48 | MP0010094_abnormal_chromosome_stability | 1.37640242 |
| 49 | MP0006082_CNS_inflammation | 1.35764516 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.35763307 |
| 51 | MP0003091_abnormal_cell_migration | 1.35235558 |
| 52 | MP0003828_pulmonary_edema | 1.34846424 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.30221401 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.29628225 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.29560731 |
| 56 | MP0003077_abnormal_cell_cycle | 1.29266163 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.25755576 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.25755576 |
| 59 | MP0003111_abnormal_nucleus_morphology | 1.25205153 |
| 60 | MP0008260_abnormal_autophagy | 1.24436588 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.23176634 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.20425488 |
| 63 | MP0000858_altered_metastatic_potential | 1.20146488 |
| 64 | MP0005409_darkened_coat_color | 1.18847259 |
| 65 | MP0000490_abnormal_crypts_of | 1.15481554 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.14756598 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.14311409 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.13528018 |
| 69 | MP0003866_abnormal_defecation | 1.11959197 |
| 70 | MP0010307_abnormal_tumor_latency | 1.11955632 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.10627613 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.08239743 |
| 73 | MP0005310_abnormal_salivary_gland | 1.03434156 |
| 74 | MP0004957_abnormal_blastocyst_morpholog | 1.03196757 |
| 75 | MP0002132_abnormal_respiratory_system | 1.00901624 |
| 76 | MP0004233_abnormal_muscle_weight | 1.00513419 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 0.96479920 |
| 78 | MP0001853_heart_inflammation | 0.96313978 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.94639192 |
| 80 | MP0005621_abnormal_cell_physiology | 0.92141689 |
| 81 | MP0000371_diluted_coat_color | 0.91345995 |
| 82 | MP0001873_stomach_inflammation | 0.91314777 |
| 83 | MP0009115_abnormal_fat_cell | 0.87734092 |
| 84 | MP0002086_abnormal_extraembryonic_tissu | 0.86953343 |
| 85 | MP0000350_abnormal_cell_proliferation | 0.86851770 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.86117168 |
| 87 | MP0000313_abnormal_cell_death | 0.85151332 |
| 88 | MP0001915_intracranial_hemorrhage | 0.84944321 |
| 89 | MP0001851_eye_inflammation | 0.84209303 |
| 90 | MP0003984_embryonic_growth_retardation | 0.82463959 |
| 91 | MP0001672_abnormal_embryogenesis/_devel | 0.80623188 |
| 92 | MP0005380_embryogenesis_phenotype | 0.80623188 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.80618518 |
| 94 | MP0002088_abnormal_embryonic_growth/wei | 0.80586284 |
| 95 | MP0008469_abnormal_protein_level | 0.78708367 |
| 96 | MP0001730_embryonic_growth_arrest | 0.77545604 |
| 97 | MP0004883_abnormal_blood_vessel | 0.76992941 |
| 98 | MP0003448_altered_tumor_morphology | 0.73645837 |
| 99 | MP0003045_fibrosis | 0.72981656 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.72977032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.10586865 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 3.88483623 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84495081 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.78961098 |
| 5 | Recurrent viral infections (HP:0004429) | 3.62222546 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.48307015 |
| 7 | T lymphocytopenia (HP:0005403) | 3.45239243 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 3.44300460 |
| 9 | Abnormality of the fingertips (HP:0001211) | 3.36095033 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.22547637 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 3.09313892 |
| 12 | Viral hepatitis (HP:0006562) | 3.05089899 |
| 13 | Increased IgE level (HP:0003212) | 3.03319944 |
| 14 | Meningitis (HP:0001287) | 3.02084382 |
| 15 | Myositis (HP:0100614) | 2.98658789 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 2.94496494 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85927623 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85927623 |
| 19 | Spontaneous hematomas (HP:0007420) | 2.82991729 |
| 20 | Granulocytopenia (HP:0001913) | 2.78659940 |
| 21 | Abnormality of macrophages (HP:0004311) | 2.78604003 |
| 22 | Encephalitis (HP:0002383) | 2.76313105 |
| 23 | Abnormality of T cells (HP:0002843) | 2.75341515 |
| 24 | Recurrent skin infections (HP:0001581) | 2.70638647 |
| 25 | Optic neuritis (HP:0100653) | 2.67844964 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 2.67844964 |
| 27 | Colitis (HP:0002583) | 2.66676181 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 2.63798415 |
| 29 | Acute myeloid leukemia (HP:0004808) | 2.63415236 |
| 30 | Cellulitis (HP:0100658) | 2.62974615 |
| 31 | Subacute progressive viral hepatitis (HP:0006572) | 2.62758468 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62296448 |
| 33 | Orchitis (HP:0100796) | 2.61650007 |
| 34 | Fatigue (HP:0012378) | 2.61183237 |
| 35 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.59697961 |
| 36 | Obstructive lung disease (HP:0006536) | 2.57692973 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.57692973 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50701620 |
| 39 | Gingivitis (HP:0000230) | 2.47284709 |
| 40 | Syringomyelia (HP:0003396) | 2.46235428 |
| 41 | Spinal cord lesions (HP:0100561) | 2.46235428 |
| 42 | Vasculitis (HP:0002633) | 2.43749085 |
| 43 | Eosinophilia (HP:0001880) | 2.43219804 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.42856997 |
| 45 | Osteomyelitis (HP:0002754) | 2.42642009 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.40734803 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.38746914 |
| 48 | Lymphopenia (HP:0001888) | 2.37632040 |
| 49 | Abnormality of the peritoneum (HP:0002585) | 2.36430052 |
| 50 | Arterial thrombosis (HP:0004420) | 2.36199014 |
| 51 | Chest pain (HP:0100749) | 2.33232256 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.31015254 |
| 53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27718258 |
| 54 | Severe combined immunodeficiency (HP:0004430) | 2.26144099 |
| 55 | Combined immunodeficiency (HP:0005387) | 2.25678329 |
| 56 | Gastrointestinal stroma tumor (HP:0100723) | 2.24570529 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.23552915 |
| 58 | Leukocytosis (HP:0001974) | 2.23475265 |
| 59 | B lymphocytopenia (HP:0010976) | 2.19214459 |
| 60 | Pustule (HP:0200039) | 2.18813744 |
| 61 | Autoimmune thrombocytopenia (HP:0001973) | 2.15358330 |
| 62 | Abnormality of the columella (HP:0009929) | 2.15178119 |
| 63 | Papilledema (HP:0001085) | 2.15128283 |
| 64 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.14456090 |
| 65 | Papillary thyroid carcinoma (HP:0002895) | 2.13619591 |
| 66 | Abnormality of B cell number (HP:0010975) | 2.10852307 |
| 67 | Acute lymphatic leukemia (HP:0006721) | 2.10642639 |
| 68 | Curly hair (HP:0002212) | 2.07521064 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.04538652 |
| 70 | Slow saccadic eye movements (HP:0000514) | 2.03096415 |
| 71 | Ankyloglossia (HP:0010296) | 2.02605590 |
| 72 | Myelodysplasia (HP:0002863) | 2.01550071 |
| 73 | Lymphoma (HP:0002665) | 2.01153677 |
| 74 | Prominent nose (HP:0000448) | 1.97141505 |
| 75 | Chronic otitis media (HP:0000389) | 1.95918252 |
| 76 | Emphysema (HP:0002097) | 1.93718942 |
| 77 | Peritonitis (HP:0002586) | 1.93379082 |
| 78 | Urticaria (HP:0001025) | 1.91040217 |
| 79 | Chromsome breakage (HP:0040012) | 1.90785778 |
| 80 | Abnormality of eosinophils (HP:0001879) | 1.89119476 |
| 81 | Verrucae (HP:0200043) | 1.88244103 |
| 82 | Papilloma (HP:0012740) | 1.88244103 |
| 83 | Polycythemia (HP:0001901) | 1.87794102 |
| 84 | Myocardial infarction (HP:0001658) | 1.87366378 |
| 85 | Chronic diarrhea (HP:0002028) | 1.86085938 |
| 86 | Basal cell carcinoma (HP:0002671) | 1.85371700 |
| 87 | Abnormality of the endocardium (HP:0004306) | 1.85094974 |
| 88 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.83827359 |
| 89 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.83173712 |
| 90 | Heterotopia (HP:0002282) | 1.82836361 |
| 91 | Keratoconjunctivitis (HP:0001096) | 1.82808560 |
| 92 | Micronodular cirrhosis (HP:0001413) | 1.80987869 |
| 93 | Amaurosis fugax (HP:0100576) | 1.79842572 |
| 94 | Deep palmar crease (HP:0006191) | 1.79407741 |
| 95 | Abnormality of the thymus (HP:0000777) | 1.79301917 |
| 96 | Anorexia (HP:0002039) | 1.77737446 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.77206463 |
| 98 | Sepsis (HP:0100806) | 1.77105601 |
| 99 | Pulmonary infiltrates (HP:0002113) | 1.75505325 |
| 100 | Somatic mutation (HP:0001428) | 1.75323081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.51247753 |
| 2 | MAP3K14 | 3.27410479 |
| 3 | PRPF4B | 2.79064034 |
| 4 | CDK12 | 2.64529971 |
| 5 | MAP4K1 | 2.61655478 |
| 6 | MAP3K10 | 2.37405950 |
| 7 | MAP3K13 | 2.25412681 |
| 8 | IRAK4 | 2.18007648 |
| 9 | LATS1 | 2.09718217 |
| 10 | KSR2 | 2.06091932 |
| 11 | MARK3 | 2.04118525 |
| 12 | BRD4 | 2.03483878 |
| 13 | FGFR4 | 2.02974564 |
| 14 | TYK2 | 2.01318913 |
| 15 | JAK3 | 1.88537335 |
| 16 | BTK | 1.87703014 |
| 17 | PKN2 | 1.83782121 |
| 18 | BLK | 1.75670872 |
| 19 | SIK3 | 1.69750774 |
| 20 | ZAP70 | 1.62799986 |
| 21 | EIF2AK3 | 1.61915448 |
| 22 | FGFR3 | 1.52819141 |
| 23 | JAK1 | 1.50158238 |
| 24 | CSK | 1.49093535 |
| 25 | MAP3K9 | 1.45255655 |
| 26 | SMG1 | 1.44122847 |
| 27 | ERN1 | 1.40247838 |
| 28 | NLK | 1.40225044 |
| 29 | TAOK3 | 1.38446074 |
| 30 | KSR1 | 1.36390144 |
| 31 | EPHB1 | 1.28945943 |
| 32 | TRIB3 | 1.23956112 |
| 33 | MAP2K3 | 1.21324177 |
| 34 | HCK | 1.20622052 |
| 35 | MAP3K2 | 1.17188803 |
| 36 | TEC | 1.16860573 |
| 37 | SCYL2 | 1.16790902 |
| 38 | MAP3K6 | 1.14550853 |
| 39 | SYK | 1.14413542 |
| 40 | MAP3K1 | 1.14317186 |
| 41 | IKBKE | 1.11289507 |
| 42 | YES1 | 1.10291775 |
| 43 | CLK1 | 1.08420395 |
| 44 | JAK2 | 1.07563241 |
| 45 | STK38 | 1.04736501 |
| 46 | RAF1 | 1.04230091 |
| 47 | FGR | 1.02053022 |
| 48 | SIK2 | 1.01865229 |
| 49 | WNK1 | 1.01277804 |
| 50 | GRK6 | 0.95297698 |
| 51 | MARK2 | 0.92517955 |
| 52 | RET | 0.92416972 |
| 53 | FES | 0.90191178 |
| 54 | NEK2 | 0.89861792 |
| 55 | MELK | 0.86046049 |
| 56 | TXK | 0.85994379 |
| 57 | IRAK1 | 0.84134526 |
| 58 | CDK4 | 0.83189817 |
| 59 | LYN | 0.83105388 |
| 60 | ITK | 0.83068393 |
| 61 | EEF2K | 0.81728173 |
| 62 | TBK1 | 0.81575298 |
| 63 | CDK6 | 0.81049532 |
| 64 | IRAK2 | 0.76001701 |
| 65 | MAPK11 | 0.75279798 |
| 66 | MST1R | 0.75023605 |
| 67 | MAP3K8 | 0.69696098 |
| 68 | LCK | 0.69131516 |
| 69 | MAP3K7 | 0.68173697 |
| 70 | NEK9 | 0.67770722 |
| 71 | BMPR2 | 0.66807321 |
| 72 | CDC42BPA | 0.66008118 |
| 73 | STK24 | 0.59853078 |
| 74 | STK10 | 0.58600095 |
| 75 | SGK3 | 0.52569497 |
| 76 | TRPM7 | 0.51614392 |
| 77 | WEE1 | 0.51468569 |
| 78 | STK38L | 0.51340014 |
| 79 | MAP3K5 | 0.50457659 |
| 80 | ICK | 0.49796712 |
| 81 | PRKCQ | 0.48890008 |
| 82 | CDK7 | 0.48770180 |
| 83 | STK4 | 0.45415585 |
| 84 | RIPK1 | 0.44891927 |
| 85 | IKBKB | 0.44498652 |
| 86 | STK3 | 0.44388328 |
| 87 | TNK2 | 0.43747756 |
| 88 | PTK6 | 0.43110953 |
| 89 | PIM1 | 0.42732138 |
| 90 | CSF1R | 0.42488323 |
| 91 | PDK1 | 0.41758758 |
| 92 | CAMK1D | 0.39482110 |
| 93 | PDGFRB | 0.39027224 |
| 94 | MTOR | 0.38990437 |
| 95 | TGFBR2 | 0.38690468 |
| 96 | PDGFRA | 0.38327533 |
| 97 | IRAK3 | 0.37924775 |
| 98 | EGFR | 0.37648483 |
| 99 | RPS6KB2 | 0.37512436 |
| 100 | KIT | 0.35920027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.69772374 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.18778081 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99450067 |
| 4 | Measles_Homo sapiens_hsa05162 | 1.99304493 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.94172207 |
| 6 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.93413823 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92834881 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.85684408 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.85628543 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.84404509 |
| 11 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.78366248 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77924284 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74162942 |
| 14 | Hepatitis B_Homo sapiens_hsa05161 | 1.71466445 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67708459 |
| 16 | Endometrial cancer_Homo sapiens_hsa05213 | 1.58302395 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57128171 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56524711 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.53459648 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49105351 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45775851 |
| 22 | Prostate cancer_Homo sapiens_hsa05215 | 1.41452630 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.40714509 |
| 24 | Thyroid cancer_Homo sapiens_hsa05216 | 1.40600708 |
| 25 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.39339529 |
| 26 | Hepatitis C_Homo sapiens_hsa05160 | 1.38441506 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37268915 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34079682 |
| 29 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.33814226 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32399588 |
| 31 | Colorectal cancer_Homo sapiens_hsa05210 | 1.28482141 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.28156987 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26900556 |
| 34 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.18513711 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17350614 |
| 36 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14841773 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13740962 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10967739 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.10605649 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10328776 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08935082 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07786388 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06961096 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05554723 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04499363 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03945741 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02598148 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02171820 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.02013699 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00524767 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.99181506 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98844990 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.98506103 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97031629 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96622110 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96068256 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95257418 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94473918 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93559844 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92170658 |
| 61 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.89879158 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89870916 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89260067 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.88564270 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87513720 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.86843803 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84051993 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83629717 |
| 69 | Cell cycle_Homo sapiens_hsa04110 | 0.81349713 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80450872 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77654472 |
| 72 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.77480632 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75965796 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.75774393 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.73912822 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71676933 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70719669 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67968017 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67656443 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66604282 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61016375 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60632112 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.60582376 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59426689 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58647676 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.57286580 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54491195 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54436416 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52055043 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51023638 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50019371 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.49132371 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48797726 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48100006 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48052564 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.47530519 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46735893 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46633664 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.46009368 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45033928 |

